Diambra and colleagues1 integrated metabolic dysfunction-associated steatotic liver disease phenotypes with proteomics to derive a four-protein mortality score (PS4: FTCD, FABP1, ADGRG1 and GAST). We ...
Snijkers and colleagues should be congratulated for completing a multicentre, three-arm randomised trial of gut-directed ...
Risk stratification in compensated advanced chronic liver disease has traditionally been based on the identification of ...
a Department of Surgery, University of Heidelberg, Heidelberg, Germany, b Department of Immunochemistry, German Cancer Research Center, Heidelberg, Germany Dr B Sido, Department of Surgery, University ...
Department of Medicine, Division of Digestive Diseases and Gastroenterology, UCLA Medical Centre and Beth Israel Deaconess Medical Centre, Los Angeles, California, USA Dr T Lembo, Beth Israel ...
Correspondence to Dr Gert Van Assche, University Hospital Leuven, Centre for GI research, University of Leuven, B-3000 Leuven, Belgium; gert.vanassche{at}uz.kuleuven.ac.be Acute severe ulcerative ...
Correspondence to Shumei Song, Departmental of GI Medical Oncology, U.T.MD. Anderson Cancer Center, Houston, TX 77030, USA; ssong{at}mdanderson.org; Jaffer A Ajani ...
Correspondence to Dr Evelien Dekker, Department of Gastroenterology and Hepatology, Academic Medical Centre, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands; e.dekker{at}amc.uva.nl Objective ...
We read with interest the study by Higuchi et al , which identified mechanisms of increased satiation in Cyp8b1−/− mice via slowed gastric empting.1 Following data showing that deleting Cyp8b1, which ...
4 Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Hills Road, Cambridge, UK Correspondence to Ashraf E K Ibrahim, Department of Pathology, Division of Molecular ...
2 Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore Objective Alcoholic hepatitis (AH) reflects acute exacerbation of alcoholic liver ...
METHODS In a double blind multicentre trial, 120 patients were randomly assigned to receive budesonide 6 mg once daily or placebo. Prednisolone was tapered to zero during the first 4–10 weeks and ...